| Dr Hoang M Nguyen, PHARM D | |
|
101 N China Lake Blvd, Ridgecrest, CA 93555-3915 | |
| (760) 375-0223 | |
| Not Available |
| Full Name | Dr Hoang M Nguyen |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 101 N China Lake Blvd, Ridgecrest, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053627935 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 60586 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hoang M Nguyen, PHARM D 101 N China Lake Blvd, Ridgecrest, CA 93555-3915 Ph: (760) 375-0223 | Dr Hoang M Nguyen, PHARM D 101 N China Lake Blvd, Ridgecrest, CA 93555-3915 Ph: (760) 375-0223 |
News Archive
The British Association of Aesthetic Plastic Surgeons (www.baaps.org.uk), the not-for-profit organisation established for the advancement of education and practice of Aesthetic Plastic Surgery for public benefit, today announced the results of their annual audit for 2007.
At the 2013 World Molecular Imaging Congress (WMIC, www.wmicmeeting.org), Bruker today announced the world's first Magnetic Particle Imaging (MPI) system, an entirely new technology for preclinical imaging. The addition of MPI as a complementary preclinical imaging technique for disease studies, translational research and drug discovery, has significant potential in helping researchers gain new insights into disease processes at the organ, cellular and molecular level.
Building upon more than two decades of basic research conducted at Children's Hospital Los Angeles, Araz Marachelian, MD, of CHLA, and her colleagues at pediatric academic centers across the U. S., have shown that an immunotherapy that until now has only been available to patients enrolled in research studies, is equivalent to the product that has been manufactured for commercial use and can be made available to all patients.
Running large, multi-gene sequencing panels to assess cancer risk is a growing trend in medicine as the price of the technology declines and more precise approaches to cancer care gain steam. The tests are particularly common among breast and ovarian cancer patients. However, questions remain about the growing list of mutations and their suspected, but unproven association with breast and ovarian cancer risk.
The U.S. Food and Drug Administration today approved HEMACORD, the first licensed hematopoietic progenitor cells-cord (HPC-C) cell therapy.
› Verified 5 days ago
Dr. William P Martin Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 Administration Cir, Ridgecrest, CA 93555 Phone: 760-939-8030 | |
Hanh Huu Hong Nguyen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 W Drummond Ave, Ridgecrest, CA 93555 Phone: 760-384-2358 | |
Dr. Richard Frederick Ii, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 N China Lake Blvd, Ridgecrest, CA 93555 Phone: 703-375-0223 | |
Katherine Ling Caras, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 927 S China Lake Blvd, Ridgecrest, CA 93555 Phone: 760-384-4020 Fax: 760-384-1456 | |
Vu Hoan Tran, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1109 N China Lake Blvd, Ridgecrest, CA 93555 Phone: 760-446-4141 | |
Sung Chung, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 101 N China Lake Blvd, Ridgecrest, CA 93555 Phone: 760-375-0223 |